Shiseido has signed a binding agreement to sell its Chinese subsidiary, Shiseido Liyuan Cosmetics (SLC), to an investor consortium led by Hong Kong-based private equity firm IDG Capital. SLC makes and sells the Aupres brand in China, and the transaction covers the entire company.
The deal is expected to close between the fourth quarter of 2026 and the first quarter of 2027, subject to regulatory approvals, including in China. Shiseido did not disclose the financial terms.
Ownership and transition
Under the proposed structure, funds managed by IDG Capital will hold 95% of the equity through two special purpose vehicles. A limited partnership set up mainly by SLC’s new management team will hold the remaining 5%. The transaction includes SLC’s Beijing factory and production equipment.
Shiseido said it will license the intellectual property rights that IDG needs to run the business. For a specified period after the transfer, Shiseido will also provide support for new product development, technical assistance for the stable supply of existing products, and continued supply of raw materials and selected products. The company said the arrangements are intended to maintain SLC’s innovation capabilities, product quality and business continuity.
Strategic rationale
The divestment is part of Shiseido’s push to improve profitability and capital efficiency under its 2030 Medium-Term Strategy. The Japanese cosmetics group said it wants to focus management resources on areas where it enjoys the greatest competitive advantage, and on priority brands and higher-growth opportunities.
Shiseido described SLC as a business that needs continued investment in product innovation and digital capabilities. It said the sale allows the group to concentrate on its chosen priorities. At the same time, Shiseido called China a strategically important and attractive market, while noting that the competitive landscape continues to evolve with rapid e-commerce expansion, changing consumer behavior and the emergence of diverse market participants.
Joint venture background
SLC was established in 1991 as a joint venture with Beijing Liyuan, a subsidiary of Yiqing Group, which is owned by the Beijing Municipal Government. SLC has sold the C-beauty brand Aupres since 1994.
The current joint venture agreement is due to expire in December 2026, and the parties agreed not to renew it. On September 1, 2026, Shiseido acquired Beijing Liyuan’s 35% stake, giving it full ownership ahead of the sale.
Shiseido believes that independent operation under IDG will support SLC’s sustainable growth and brand value.
Financial context
The divestment comes days after Shiseido reported a 124.3% jump in core operating profit for the third quarter of 2026, to ¥67.5 billion (US$422.13 million). The company attributed the recovery to restructuring, cost cuts and improved margins rather than strong product demand; like-for-like sales grew 0.7%.
Shiseido raised its full-year core operating profit forecast from ¥59 billion (US$433 million) to ¥87 billion (US$546 million) on the back of those results.
